Profile
- clinical development
- Boston
- 6,064 followers
„We cannot buy culture, we have to build it” – Mike Jagielski, CEO
Values
- Learning
- Customer Focus
- Accountability
- Commitment
- Tenacity to Succeed
Development goals
- Be the clinical development partner of choice for global biotech
- Innovate in the direct patient engagement area
- Adapt to novel technology and development strategies
- Remain a private business enterprise to ensure long-term development
Social responsibility
- Contributing to hospices in Eastern Europe
- Supporting the orphanage in Poland
- Being environmentally conscious: office space, materials and recycling
- Caring for KCR team & supporting employees in need
#HBEN NGO
- HBEN NGO was created to understand real patient experiences
- Patient engagement allows for better communication & innovation
- Patient feedback leads to essential progress in trial design & execution
Media
Contract Pharma
20 May 2020
Pioneering Medicine Forward
Medium
12 May 2020
KCR’s Bryan Katz named in PM360’s ELITE 100
Medium
08 April 2020
New FDA Guidelines on validation of software systems: What do they mean for Quality Assurance?
Medium
08 January 2020
KCR adopts Veeva Vault Clinical Suite
PharmaVoice
27 November 2019
Creating Culture of Innovation
Medium
27 November 2019
Future digitalization of the CRO industry
Medium
07 November 2019
Immuno-Oncology Trial Implementation – Where to Start? KCR’s Webinar
Medium
09 October 2019
Consulting in the Life Sciences Industry: Making the World Small for You
Applied Clinical Trials
17 September 2019
European Regulatory Framework and General Path to Market for ATMPs
Journal of Drug Assessment
09 July 2019
Epidemiology of atopic dermatitis in Europe
Medium
09 July 2019
The Next Frontier for Regulators: Virtual & Hybrid Clinical Trials
Twitter
28 May 2019
We are so excited to welcome you to the #KCR Twitter page! We look forward to engaging with you all.
YouTube
20 September 2018
KCR Annual Development Meeting | Interviews | Part 2
If you would like to know more
feel free to...